Zika virus reference material, prepared by PEI on behalf of the WHO, is available for advance distribution
As of Monday 25 July 2016, the WHO reference material for Zika virus RNA can be obtained from the PEI. It is expected to be endorsed in October 2016 at the Annual Meeting of the WHO Expert Committee on Biological Standardization (ECBS). In the meantime, the candidate reference material is available in advance in agreement with the WHO due to the ongoing Zika virus public health emergency.
CAR-T cells with Sleeping Beauty transposons successfully created – more efficiency coupled with a lower risk of insertional mutagenesis?
Researchers of the University Hospital of Würzburg, and the Paul-Ehrlich-Institut have jointly developed a method enabling them to create so-called CAR T-cells (cells with chimeric antigen receptors) in an efficient manner using Sleeping Beauty transposons. CAR T-cell therapies rank among the most promising tumour therapies and are currently in the clinical trial stage.
VAC2VAC- Contribution of the Paul-Ehrlich-Institut
VAC2VAC is a wide-ranging collaborative research project funded by IMI2 which aims to develop and validate quality testing approaches for both human and veterinary vaccines using non-animal methods. The Paul-Ehrlich-Institut is a partner in this project.